Skip to main content
  • Cathepsin B Inhibition Abrogates the Invasive Phenotype of Medulloblastoma

    Final Number:

    Xuezhe Han MD, PhD; Michael Robert Raber MD; Brendan McNeish; Akino Tomoshige; Rajarshi Majumder; Edward R. Smith MD

    Study Design:
    Laboratory Investigation

    Subject Category:

    Meeting: Congress of Neurological Surgeons 2013 Annual Meeting

    Introduction: Medulloblastoma is the most common malignant brain tumor of children. Poor prognosis is associated with an invasive phenotype, characterized by proliferation and the ability to invade surrounding tissue. Our laboratory and colleagues have identified that activity of the protease cathepsin B is strongly associated with the invasive phenotype. We hypothesized that inhibition of cathepsin B would result in a reduction of these tumor-related activities. In this study, we investigated the therapeutic potential of a cathepsin B inhibitor, CA074ME, in medulloblastoma.

    Methods: Established human medulloblastoma cell lines were grown and baseline proliferation and invasion characteristics were quantitated using the Cell Counting Kit-8 (CCK8) assay for proliferation and the trans-well invasion assay was used for invasion. Cell lines were then treated with increasing concentrations of CA074ME, with changes in proliferation and invasion measured then subjected to standard statistical analysis.

    Results: Inhibition of cathepsin B with CA074ME produced a dose-dependent reduction, up to 4-fold in magnitude, of proliferation of medulloblastoma cell lines (with the exception of extremely low doses, which had a paradoxical effect on proliferation). Similarly, invasion was significantly reduced by ~75% in a dose-dependent manner.

    Conclusions: Inhibition of cathepsin B markedly influences medulloblastoma phenotype, reducing both proliferation and invasion in a dose-dependent manner. These data suggest a novel method to pharmacologically target clinically significant tumor activity.

    Patient Care: This research offers insight to possible new brain tumor treatments.

    Learning Objectives: By the conclusion of this session, participants should be able to (1) discuss the importance of the invasive phenotype in medulloblastoma, (2) describe the influence of proteases on the invasive phenotype of medulloblastoma and (3) identify the potential utility of pharmacologic blockade of cathepsin B in this tumor type

    References: Netrin-1 promotes glioblastoma cell invasiveness and angiogenesis by multiple pathways including activation of RhoA, cathepsin B, and cAMP-response element-binding protein. Shimizu A, Nakayama H, Wang P, König C, Akino T, Sandlund J, Coma S, Italiano JE Jr, Mammoto A, Bielenberg DR, Klagsbrun M. Urinary biomarkers predict brain tumor presence and response to therapy. Smith ER, Zurakowski D, Saad A, Scott RM, Moses MA. Clin Cancer Res. 2008 Apr 15;14(8):2378-86.

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy